Company News in the Life Science Industry

»

Reset 

Zucara Therapeutics Announces US$21 Million Series A Financing

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Zucara Therapeutics Inc.

BIOCARDIA ANNOUNCES POSITIVE DSMB RECOMMENDATION TO CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY, AS PLANNED

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  BioCardia, Inc.

Alimera Sciences Appoints Steven T. Gill to the Newly Created Position of Vice President, Thought Leader Engagement

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Alimera Sciences, Inc.

iCAD Announces New Credit Facility with Bridge Bank, Increasing Operational Flexibility

Read more ››
By: GlobenewsWire - 31 Mar 2020

Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Cambrex Corporation

Axovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Axovant Gene Therapies

Resverlogix Announces Participation at the American College of Cardiology Scientific Sessions together with the World Congress of Cardiology Virtual

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Resverlogix Corp.

Cybrexa Therapeutics Announces Arthur DeCillis, MD as Acting Chief Medical Officer to Support CBX-12’s Entry into the Clinic

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Cybrexa Therapeutics

Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Kiniksa Pharmaceuticals Corp.

Denver-Based Nonprofit Launches National Organization to Educate Public and Develop Leadership in Psychedelic Ecosystem

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  SporeGen Limited

Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies

Read more ››
By: GlobenewsWire - 31 Mar 2020

Agritek Holdings, Inc. Announces Delay in Filing Form 10-K Report Under New SEC Provision for COVID-19 with Full Intention of Remaining Fully Reporting and Uplisting to OTCQB

Read more ››
By: GlobenewsWire - 31 Mar 2020

Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Xenon Pharmaceuticals Inc.

Bellerophon Therapeutics to Host Investor Call and Webcast Today on INOpulse® for the Treatment of COVID-19

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Bellerophon Therapeutics, Inc.

POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer

Read more ››
By: GlobenewsWire - 31 Mar 2020

Press release Oncology Venture establishes a convertible note program of 100 million SEK

Read more ››
By: GlobenewsWire - 31 Mar 2020

Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc.

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  BioSig Technologies, Inc.

OrthoPediatrics Corp. Receives FDA 510(k) Clearance and Expanded Neuromuscular Indications for its RESPONSE™ Scoliosis System

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  OrthoPediatrics Corp.

Chiesi USA increases support measures for employees, patients and community partners in response to COVID-19 pandemic

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  Chiesi USA, Inc.

Athenahealth’s Nationwide Network Delivers Data Insights that Contribute to Country’s Real-Time Learning and Response to COVID-19 Pandemic

Read more ››
By: GlobenewsWire - 31 Mar 2020
Related companies:  athenahealth, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 50,000 companies